2025-04-02 - Analysis Report
## Philip Morris International Inc (PM) Stock Analysis

**0) Introduction:** This report analyzes Philip Morris International Inc. (PM), a leading international tobacco company, based on provided financial data.  We will compare its performance against the S&P 500 (VOO), examine key metrics, and provide a summary conclusion.

**1) Performance Comparison with S&P 500:**

Philip Morris International (PM) shows a cumulative return of 117.92% compared to the S&P 500 (VOO) with a cumulative return of 89.83%. This represents a difference of 28.1 percentage points.  The relative divergence, considering historical volatility, is 98%, indicating PM's performance is currently at the high end of its historical range relative to the S&P 500.


**Alpha and Beta Analysis:**

The provided data shows fluctuating alpha and beta values across different time periods.  This suggests the stock's performance is not consistently correlated with the market. Positive alpha values (2015-2017, 2021-2023, 2022-2024, 2023-2025)  indicate outperformance relative to the market, while negative alpha values suggest underperformance. Beta values fluctuate, sometimes exceeding 1, indicating higher than average market volatility. Note that the market capitalization (Cap(B)) has generally increased throughout the period, signaling growth in company size.

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 19.0% | 8.5% | 2.0% | 0.1 | 110.7 |
| 2016-2018  | -30.0% | 50.2% | -37.0% | -0.1 | 73.8 |
| 2017-2019  | -7.0% | 50.2% | -26.0% | -0.3 | 99.7 |
| 2018-2020  | -7.0% | 50.2% | -41.0% | -0.6 | 103.3 |
| 2019-2021  | 44.0% | 13.8% | -29.0% | -0.6 | 124.8 |
| 2020-2022  | 40.0% | 46.2% | 29.0% | -0.6 | 140.2 |
| 2021-2023  | 26.0% | 46.2% | 8.0% | 0.7 | 137.6 |
| 2022-2024  | 33.0% | 50.0% | 10.0% | 0.6 | 184.8 |
| 2023-2025  | 72.0% | 78.7% | 31.0% | 0.5 | 245.9 |


**2) Recent Price Movement:**

The stock price closed at $158.73, a slight decrease of -$0.43 from the previous close.  Moving averages indicate a short-term upward trend (above the 5 and 20-day moving averages), but a longer-term trend is less clear given the position relative to the 60-day moving average.


* Closing Price: $158.73
* 5-day Moving Average: $155.09
* 20-day Moving Average: $152.34
* 60-day Moving Average: $140.59


**3) Technical Indicators:**

* **Market Risk Indicator (MRI):** 0.44 suggests a low to medium risk level.
* **RSI:** 72.39 indicates the stock is approaching overbought territory.
* **PPO:** -0.04 suggests a potential bearish signal.
* **Recent Relative Divergence:** +5.2 indicates short-term upward momentum.
* **Expected Return:** -5.2% - This negative figure implies that based on current data, a short-term decline is expected. However, a long-term (2+ years) investment could potentially yield excess returns over the S&P 500, although this requires further detailed analysis, especially considering the volatility shown in the alpha and beta analysis.


**4) Recent Earnings Analysis:**

Earnings show a general upward trend in both EPS and Revenue. However, there's a slight inconsistency in the data (duplicate entry for 2024-10-24). Further investigation is needed to confirm the accuracy of this data.

| Date       | EPS  | Revenue     |
|------------|------|-------------|
| 2024-10-24 | 1.98 | $9.91B      |
| 2024-07-25 | 1.54 | $9.47B      |
| 2024-04-26 | 1.38 | $8.79B      |
| 2023-10-26 | 1.32 | $9.14B      |
| 2024-10-24 | 1.32 | $9.14B      |


**5) Financial Information:**

Revenue shows a generally healthy upward trend. Profit margins remain high, indicating strong profitability. However, Equity is negative, and the Return on Equity (ROE) is highly variable, showing significant losses in recent quarters, which is a considerable cause for concern and warrants further investigation.


**Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2024-12-31 | $9.71B | 64.73%       |
| 2024-09-30 | $9.91B | 66.04%       |
| 2024-06-30 | $9.47B | 64.67%       |
| 2024-03-31 | $8.79B | 63.66%       |
| 2023-12-31 | $9.05B | 61.73%       |

**Capital and Profitability:**

| Quarter | Equity     | ROE         |
|---------|-------------|-------------|
| 2024-12-31 | $-11.75B   | 4.93%       |
| 2024-09-30 | $-9.69B    | -31.79%     |
| 2024-06-30 | $-9.74B    | -24.69%     |
| 2024-03-31 | $-10.31B   | -20.84%     |
| 2023-12-31 | $-11.22B   | -19.56%     |


**6) Overall Conclusion:**

PM has shown strong historical outperformance relative to the S&P 500, indicated by a high cumulative return. However, recent data reveals some contradictory signals. While revenue and profit margins remain healthy, negative equity and fluctuating ROE raise significant concerns. The high RSI suggests caution, and the negative PPO indicates potential bearish pressure. Although long-term potential exists based on its historical outperformance, a thorough investigation into the negative equity and inconsistent ROE is critical before making any investment decisions.  The substantial volatility in alpha and beta suggests a higher risk profile compared to the broad market.  Further analysis including a deeper dive into the company's financial statements and future growth prospects is needed to provide a definitive investment recommendation.  The inconsistencies in the provided data should also be addressed before drawing firm conclusions.
